CRIP1 expression in monocytes related to hypertension

Area of Science:

• Immunology
• Cardiovascular Disease
• Molecular Biology

Background:

• Hypertension is a complex disorder influenced by genetics, lifestyle, and inflammation, serving as a major risk factor for stroke, heart disease, and renal failure.
• Circulating monocytes and tissue macrophages are implicated in hypertension pathogenesis, but the precise mechanisms remain unclear.
• Cysteine rich protein 1 (CRIP1) is notably expressed in immune cells, with its monocyte expression correlating with blood pressure (BP) and increasing with pro-inflammatory stimuli.

Purpose of the Study:

• To investigate the functional link between CRIP1 expression in immune cells and blood pressure regulation.
• To explore the role of CRIP1 in the immune system's contribution to hypertension.

Main Methods:

• Studied CRIP1 expression in immune cells in relation to BP in a human cohort.
• Utilized hypertensive mouse models to examine CRIP1 expression.
• Assessed the impact of Angiotensin II (Ang II) on CRIP1 expression in splenic monocytes/macrophages and circulating monocytes.

Main Results:

• Angiotensin II (Ang II) significantly affected CRIP1 expression in splenic monocytes/macrophages and circulating monocytes at a BP-elevating dose.
• In the human cohort, higher monocytic CRIP1 expression levels were associated with elevated BP.
• The association between CRIP1 expression and BP was diminished upon monocyte differentiation into macrophages.

Conclusions:

• CRIP1-positive circulating and splenic monocytes appear to be crucial in hypertension-associated inflammatory processes, potentially mediated by endogenous hormones like Ang II.
• These findings suggest CRIP1 influences the interplay between the immune system, specifically monocytes, and the development of hypertension.